Cyclacel Pharmaceuticals (STU:UXI) Total Assets : €4.85 Mil (As of Sep. 2024)

Cyclacel Pharmaceuticals Total Assets Chart

Cyclacel Pharmaceuticals Annual Data
	Trend	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
Total Assets		Get a 7-Day Free Trial					13.78	30.25	38.18	26.48	8.07

Cyclacel Pharmaceuticals Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Assets	Get a 7-Day Free Trial															11.71	8.07	5.67	7.61	4.85

Cyclacel Pharmaceuticals Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Cyclacel Pharmaceuticals's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Cyclacel Pharmaceuticals's Total Assets for the quarter that ended in Sep. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cyclacel Pharmaceuticals  (STU:UXI) Total Assets Explanation

Total Assets is connected with ROA %.

Cyclacel Pharmaceuticals's annualized ROA % for the quarter that ended in Sep. 2024 is

Note: The Net Income data used here is four times the quarterly (Sep. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Cyclacel Pharmaceuticals's Asset Turnover for the quarter that ended in Sep. 2024 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Cyclacel Pharmaceuticals Total Assets Related Terms

Thank you for viewing the detailed overview of Cyclacel Pharmaceuticals's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Cyclacel Pharmaceuticals Business Description